236 related articles for article (PubMed ID: 24852654)
1. Regulated genes in psoriatic skin during treatment with fumaric acid esters.
Onderdijk AJ; Balak DM; Baerveldt EM; Florencia EF; Kant M; Laman JD; van IJcken WF; Racz E; de Ridder D; Thio HB; Prens EP
Br J Dermatol; 2014 Oct; 171(4):732-41. PubMed ID: 24852654
[TBL] [Abstract][Full Text] [Related]
2. Topical calcipotriol plus oral fumaric acid is more effective and faster acting than oral fumaric acid monotherapy in the treatment of severe chronic plaque psoriasis vulgaris.
Gollnick H; Altmeyer P; Kaufmann R; Ring J; Christophers E; Pavel S; Ziegler J
Dermatology; 2002; 205(1):46-53. PubMed ID: 12145434
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of etanercept in psoriasis after switching from other treatments: an observational study.
Mazzotta A; Esposito M; Costanzo A; Chimenti S
Am J Clin Dermatol; 2009; 10(5):319-24. PubMed ID: 19658444
[TBL] [Abstract][Full Text] [Related]
4. Treatment of severe, recalcitrant, chronic plaque psoriasis with fumaric acid esters: a prospective study.
Wain EM; Darling MI; Pleass RD; Barker JN; Smith CH
Br J Dermatol; 2010 Feb; 162(2):427-34. PubMed ID: 19519838
[TBL] [Abstract][Full Text] [Related]
5. Fumaric acid esters in combination with a 6-week course of narrowband ultraviolet B provides an accelerated response compared with fumaric acid esters monotherapy in patients with moderate-to-severe plaque psoriasis: a randomized prospective clinical study.
Tzaneva S; Geroldinger A; Trattner H; Tanew A
Br J Dermatol; 2018 Mar; 178(3):682-688. PubMed ID: 29114862
[TBL] [Abstract][Full Text] [Related]
6. A randomized study to evaluate the efficacy and safety of adding topical therapy to etanercept in patients with moderate to severe plaque psoriasis.
Lebwohl MG; Kircik L; Callis Duffin K; Pariser D; Hooper M; Wenkert D; Thompson EH; Yang J; Kricorian G; Koo J
J Am Acad Dermatol; 2013 Sep; 69(3):385-92. PubMed ID: 23643256
[TBL] [Abstract][Full Text] [Related]
7. Secukinumab is superior to fumaric acid esters in treating patients with moderate-to-severe plaque psoriasis who are naive to systemic treatments: results from the randomized controlled PRIME trial.
Sticherling M; Mrowietz U; Augustin M; Thaçi D; Melzer N; Hentschke C; Kneidl J; Sieder C; Reich K
Br J Dermatol; 2017 Oct; 177(4):1024-1032. PubMed ID: 28580646
[TBL] [Abstract][Full Text] [Related]
8. Early tissue responses in psoriasis to the antitumour necrosis factor-α biologic etanercept suggest reduced interleukin-17 receptor expression and signalling.
Johnston A; Guzman AM; Swindell WR; Wang F; Kang S; Gudjonsson JE
Br J Dermatol; 2014 Jul; 171(1):97-107. PubMed ID: 24601997
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of fumaric acid esters in the long-term treatment of psoriasis--a retrospective study (FUTURE).
Reich K; Thaci D; Mrowietz U; Kamps A; Neureither M; Luger T
J Dtsch Dermatol Ges; 2009 Jul; 7(7):603-11. PubMed ID: 19459898
[TBL] [Abstract][Full Text] [Related]
10. Fumaderm® in daily practice for psoriasis: dosing, efficacy and quality of life.
Walker F; Adamczyk A; Kellerer C; Belge K; Brück J; Berner T; Merten K; Núnez Gómez N; Neureither M; Röcken M; Ghoreschi K;
Br J Dermatol; 2014 Nov; 171(5):1197-205. PubMed ID: 24813676
[TBL] [Abstract][Full Text] [Related]
11. Systemic treatment with fumaric acid esters in six paediatric patients with psoriasis in a psoriasis centre.
Steinz K; Gerdes S; Domm S; Mrowietz U
Dermatology; 2014; 229(3):199-204. PubMed ID: 25247273
[TBL] [Abstract][Full Text] [Related]
12. Drug survival of fumaric acid esters for psoriasis: a retrospective study.
Ismail N; Collins P; Rogers S; Kirby B; Lally A
Br J Dermatol; 2014 Aug; 171(2):397-402. PubMed ID: 24471408
[TBL] [Abstract][Full Text] [Related]
13. Initial experience with routine administration of etanercept in psoriasis.
de Groot M; Appelman M; Spuls PI; de Rie MA; Bos JD
Br J Dermatol; 2006 Oct; 155(4):808-14. PubMed ID: 16965432
[TBL] [Abstract][Full Text] [Related]
14. Fumaric acid esters for psoriasis: a systematic review.
Smith D
Ir J Med Sci; 2017 Feb; 186(1):161-177. PubMed ID: 27271164
[TBL] [Abstract][Full Text] [Related]
15. Etanercept plus narrowband ultraviolet B phototherapy of psoriasis is more effective than etanercept monotherapy at 6 weeks.
Gambichler T; Tigges C; Scola N; Weber J; Skrygan M; Bechara FG; Altmeyer P; Kreuter A
Br J Dermatol; 2011 Jun; 164(6):1383-6. PubMed ID: 21466532
[TBL] [Abstract][Full Text] [Related]
16. Glutathione-S-transferase T1 genotyping and phenotyping in psoriasis patients receiving treatment with oral fumaric acid esters.
Gambichler T; Kreuter A; Susok L; Skrygan M; Rotterdam S; Höxtermann S; Müller M; Tigges C; Altmeyer P; Lahner N
J Eur Acad Dermatol Venereol; 2014 May; 28(5):574-80. PubMed ID: 23489263
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness and safety of fumaric acid esters in children with psoriasis: a retrospective analysis of 14 patients from The Netherlands.
Balak DM; Oostveen AM; Bousema MT; Venema AW; Arnold WP; Seyger MM; Thio HB
Br J Dermatol; 2013 Jun; 168(6):1343-7. PubMed ID: 23738641
[TBL] [Abstract][Full Text] [Related]
18. Effect of infliximab on health-related quality of life and disease activity by body region in patients with moderate-to-severe psoriasis and inadequate response to etanercept: results from the PSUNRISE trial.
Kalb RE; Blauvelt A; Sofen HL; Chevrier M; Amato D; Calabro S; Wang J; Schenkel B; Gottlieb AB
J Drugs Dermatol; 2013 Aug; 12(8):874-80. PubMed ID: 23986160
[TBL] [Abstract][Full Text] [Related]
19. Switching from etanercept to adalimumab is effective and safe: results in 30 patients with psoriasis with primary failure, secondary failure or intolerance to etanercept.
Van Lümig PP; Lecluse LL; Driessen RJ; Spuls PI; Boezeman JB; van de Kerkhof PC; De Jong EM
Br J Dermatol; 2010 Oct; 163(4):838-46. PubMed ID: 20649798
[TBL] [Abstract][Full Text] [Related]
20. Fumaric acid esters in severe psoriasis, including experience of use in combination with other systemic modalities.
Balasubramaniam P; Stevenson O; Berth-Jones J
Br J Dermatol; 2004 Apr; 150(4):741-6. PubMed ID: 15099371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
